Notification

No new Notification messages

Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
3b blackbio dx limited stock

3B BlackBio Dx Limited Share Price

- - (%)
- NSE: 3BBLACKBIO

3B BlackBio Dx Limited Share Price Update

As of the latest trading session, 3B BlackBio Dx Limited share price is currently at 1434.5, which is down by -40.59 from its previous closing. Today, the stock has fluctuated between 1421.25 and 1498.80. Over the past year, 3B BlackBio Dx Limited has achieved a return of 87.69 %. In the last month alone, the return has been 27.98 %. Read More...

3B BlackBio Dx Limited Performance

Day Range

Low1421.25 High1498.80
1434.50

52 Week Range

Low 660.00 High 1550.00
1434.50

3B BlackBio Dx Limited Share Price

532067

3BBLACKBIO

img img img img
No Data Available

Open Price

1498.80

Prev. Close

1475.10

Volume (Shares)

6395.00

Total traded value

91.73

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

3B BlackBio Dx Limited Fundamentals


(Standalone)

Market Cap (Cr) 1077.03
PE Ratio (TTM) 33.78
Book Value / Share 265.41
Beta 0.62
ROE 8.97%
EPS (TTM) 43.67
Dividend Yield 0.00%
Net Profit Qtr (Cr) 10.73

3B BlackBio Dx Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 17.51
Operating Expense 7.39
Net Profit 10.73
Net Profit Margin (%) 61.27
Earnings Per Share (EPS) 12.53
EBITDA 14.02
Effective Tax Rate (%) 22.18
Particulars MAR 2024 (Values in Cr)
Revenue 21.99
Operating Expense 12.13
Net Profit 9.06
Net Profit Margin (%) 41.20
Earnings Per Share (EPS) 10.57
EBITDA 14.30
Effective Tax Rate (%) 35.28
Particulars DEC 2023 (Values in Cr)
Revenue 16.96
Operating Expense 7.57
Net Profit 9.21
Net Profit Margin (%) 54.30
Earnings Per Share (EPS) 10.75
EBITDA 12.05
Effective Tax Rate (%) 22.29
Particulars SEP 2023 (Values in Cr)
Revenue 18.57
Operating Expense 10.17
Net Profit 8.48
Net Profit Margin (%) 45.66
Earnings Per Share (EPS) 9.90
EBITDA 11.41
Effective Tax Rate (%) 23.94
Particulars JUN 2023 (Values in Cr)
Revenue 13.21
Operating Expense 6.72
Net Profit 7.47
Net Profit Margin (%) 56.54
Earnings Per Share (EPS) 8.72
EBITDA 9.64
Effective Tax Rate (%) 20.95
Particulars MAR 2024 (Values in Cr)
Revenue 70.72
Operating Expense 36.58
Net Profit 34.21
Net Profit Margin (%) 48.37
Earnings Per Share (EPS) 39.93
EBITDA 47.41
Effective Tax Rate (%) 26.33
Particulars MAR 2023 (Values in Cr)
Revenue 59.34
Operating Expense 30.75
Net Profit 26.42
Net Profit Margin (%) 44.52
Earnings Per Share (EPS) 35.27
EBITDA 36.84
Effective Tax Rate (%) 26.28
Particulars MAR 2022 (Values in Cr)
Revenue 15.52
Operating Expense 17.16
Net Profit 8.01
Net Profit Margin (%) 51.61
Earnings Per Share (EPS) 10.67
EBITDA 8.86
Effective Tax Rate (%) 5.43
Particulars MAR 2021 (Values in Cr)
Revenue 14.36
Operating Expense 16.00
Net Profit 1.72
Net Profit Margin (%) 11.97
Earnings Per Share (EPS) 2.29
EBITDA 2.51
Effective Tax Rate (%) 17.78
Particulars MAR 2020 (Values in Cr)
Revenue 13.51
Operating Expense 14.30
Net Profit 0.61
Net Profit Margin (%) 4.51
Earnings Per Share (EPS) 0.82
EBITDA 1.16
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 228.55
ROE % 16.00
ROCE % 21.59
Total Debt to Total Equity 0.01
EBITDA Margin 58.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 204.26
ROE % 22.59
ROCE % 29.92
Total Debt to Total Equity 0.02
EBITDA Margin 54.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 176.27
ROE % 138.73
ROCE % 179.45
Total Debt to Total Equity 0.03
EBITDA Margin 67.43
Particulars MAR 2020 (Values in Cr)
Book Value / Share 42.87
ROE % 28.16
ROCE % 32.28
Total Debt to Total Equity 0.18
EBITDA Margin 37.82
Particulars MAR 2019 (Values in Cr)
Book Value / Share 35.21
ROE % 25.64
ROCE % 28.03
Total Debt to Total Equity 0.29
EBITDA Margin 34.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share 32.33
ROE % 8.97
ROCE % 10.81
Total Debt to Total Equity 0.09
EBITDA Margin 26.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 31.94
ROE % 34.39
ROCE % 33.57
Total Debt to Total Equity 0.10
EBITDA Margin 57.09
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.24
ROE % 7.92
ROCE % 9.48
Total Debt to Total Equity 0.13
EBITDA Margin 17.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.74
ROE % 3.34
ROCE % 4.07
Total Debt to Total Equity 0.27
EBITDA Margin 8.59
Particulars MAR 2019 (Values in Cr)
Book Value / Share 24.63
ROE % 2.74
ROCE % 4.15
Total Debt to Total Equity 0.38
EBITDA Margin 9.84
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 59.20
Total Assets 214.05
Total Liabilities 214.05
Total Equity 195.91
Share Outstanding 7508100
Price to Book Ratio 12.86
Return on Assets (%) 12.11
Return on Capital (%) 13.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 28.89
Total Assets 192.09
Total Liabilities 192.09
Total Equity 172.07
Share Outstanding 7508100
Price to Book Ratio 10.68
Return on Assets (%) 16.76
Return on Capital (%) 18.44
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 35.07
Total Assets 193.52
Total Liabilities 193.52
Total Equity 148.27
Share Outstanding 7508100
Price to Book Ratio 9.41
Return on Assets (%) 58.83
Return on Capital (%) 75.77
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.38
Total Assets 44.83
Total Liabilities 44.83
Total Equity 34.25
Share Outstanding 7508100
Price to Book Ratio 2.62
Return on Assets (%) 17.14
Return on Capital (%) 20.35
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 3.37
Total Assets 36.33
Total Liabilities 36.33
Total Equity 22.75
Share Outstanding 6408100
Price to Book Ratio 3.07
Return on Assets (%) 14.42
Return on Capital (%) 18.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.90
Total Assets 29.85
Total Liabilities 29.85
Total Equity 24.22
Share Outstanding 7508100
Price to Book Ratio 12.86
Return on Assets (%) 7.23
Return on Capital (%) 8.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.85
Total Assets 31.60
Total Liabilities 31.60
Total Equity 23.92
Share Outstanding 7508100
Price to Book Ratio 10.68
Return on Assets (%) 25.33
Return on Capital (%) 30.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.70
Total Assets 28.88
Total Liabilities 28.88
Total Equity 22.65
Share Outstanding 7508100
Price to Book Ratio 9.41
Return on Assets (%) 5.94
Return on Capital (%) 6.97
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.68
Total Assets 28.16
Total Liabilities 28.16
Total Equity 20.78
Share Outstanding 7508100
Price to Book Ratio 2.62
Return on Assets (%) 2.17
Return on Capital (%) 2.53
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 26.69
Total Liabilities 26.69
Total Equity 15.74
Share Outstanding 6408100
Price to Book Ratio 3.07
Return on Assets (%) 1.60
Return on Capital (%) 1.96
Particulars MAR 2023 (Values in Cr)
Net Income 35.30
Cash from Operations 31.84
Cash from Investing 12.11
Cash from Financing -5.00
Net change in Cash 30.01
Free Cash Flow 33.87
Particulars MAR 2022 (Values in Cr)
Net Income 43.22
Cash from Operations 47.88
Cash from Investing -28.44
Cash from Financing -15.07
Net change in Cash -6.18
Free Cash Flow 50.15
Particulars MAR 2021 (Values in Cr)
Net Income 152.03
Cash from Operations 135.40
Cash from Investing -70.25
Cash from Financing -1.56
Net change in Cash 25.69
Free Cash Flow 137.08
Particulars MAR 2020 (Values in Cr)
Net Income 10.04
Cash from Operations 9.45
Cash from Investing -0.63
Cash from Financing 0.80
Net change in Cash 7.21
Free Cash Flow 9.98
Particulars MAR 2019 (Values in Cr)
Net Income 6.95
Cash from Operations 5.15
Cash from Investing -0.69
Cash from Financing -1.08
Net change in Cash 1.78
Free Cash Flow 5.87
Particulars MAR 2023 (Values in Cr)
Net Income 2.65
Cash from Operations 2.15
Cash from Investing -0.02
Cash from Financing -2.56
Net change in Cash -0.94
Free Cash Flow 2.22
Particulars MAR 2022 (Values in Cr)
Net Income 8.46
Cash from Operations 8.14
Cash from Investing -1.52
Cash from Financing -6.30
Net change in Cash 0.14
Free Cash Flow 9.66
Particulars MAR 2021 (Values in Cr)
Net Income 2.08
Cash from Operations 3.18
Cash from Investing -0.17
Cash from Financing -1.59
Net change in Cash 1.02
Free Cash Flow 3.33
Particulars MAR 2020 (Values in Cr)
Net Income 0.61
Cash from Operations 1.10
Cash from Investing -2.45
Cash from Financing 1.42
Net change in Cash 0.07
Free Cash Flow 1.21
Particulars MAR 2019 (Values in Cr)
Net Income 0.44
Cash from Operations 0.46
Cash from Investing -0.08
Cash from Financing -0.38
Net change in Cash -0.01
Free Cash Flow 0.57
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6933.80 96.24 14.39 99697.41 4727.00 / 7043.40
FORTIS MALAR HOSPITALS LIMITED 60.90 0.00 1.04 114.14 44.00 / 107.94
SHREE PACETRONIX LTD. 180.45 22.67 4.98 64.95 138.00 / 391.90
TRANSGENE BIOTEK LTD. 8.40 0.00 5.94 63.65 3.84 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6933.80 95.13 12.92 99697.41 4727.00 / 7043.40
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 37.00 0.00 -84.67 27.64 23.00 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5485.75 30.87 6.75 6001.41 2377.20 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1455.80
  • 26 Days 1361.30
  • 10 Days 1445.70
  • 50 Days 1279.80
  • 12 Days 1448.00
  • 100 Days 1114.20
  • 20 Days 1383.60
  • 200 Days 754.30
1460.58
PIVOT
First Resistance 1485.67
Second Resistance 1505.08
Third Resistance 1530.17
First Support 1441.17
Second Support 1416.08
Third Support 1396.67
RSI 62.42
MACD 86.71
Commodity Channel Index (CCI) 71.30
ADX 50.27
Williams % R -41.18

Over 1 Month

down

27.98

Over 3 Months

down

73.12

Over 6 Months

down

74.97

Over 1 Year

down

87.69

Over 3 Years

down

41.43

Over 5 Years

down

75.89

3B BlackBio Dx Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

3B BlackBio Dx Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
55.43
Promoter Holdings
41.28
FII
3.27
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Mithla Dubey Shareholding of Promoter and Promoter Group 1059770.0 12.35
Mithala Laboratories Private Limited Shareholding of Promoter and Promoter Group 820700.0 9.56
Dhirendra Dubey Shareholding of Promoter and Promoter Group 724098.0 8.44
Varun Daga Public Shareholding 450000.0 5.24
Prateek Goel Public Shareholding 445935.0 5.2
Own Infracon Private Limited Public Shareholding 445000.0 5.18
Nikhil Kuber Dubey Shareholding of Promoter and Promoter Group 358080.0 4.17
2b Blackbio S.l. Spain Shareholding of Promoter and Promoter Group 241570.0 2.81
Maj Navraj Singh Grewal Public Shareholding 224400.0 2.61
Ark Global Emerging Companies Lp Public Shareholding 203483.0 2.37
Ram Kuber Dhirendra Kumar Shareholding of Promoter and Promoter Group 194700.0 2.27
Dalmus Performance Focused Fund Public Shareholding 141167.0 1.64
Shalu Aggarwal Public Shareholding 100633.0 1.17
Sandeep Kapadia Public Shareholding 86000.0 1.0
Rajesh Kumar Dubey Shareholding of Promoter and Promoter Group 37700.0 0.44
Madhulika Dubey Shareholding of Promoter and Promoter Group 29000.0 0.34
Santosh Kumar Dubey Shareholding of Promoter and Promoter Group 26200.0 0.31
Mahesh Kumar Upadhyay Shareholding of Promoter and Promoter Group 24500.0 0.29
Anamika Dubey Shareholding of Promoter and Promoter Group 22000.0 0.26
Sanjay Kumar Dubey Shareholding of Promoter and Promoter Group 5100.0 0.06

3B BlackBio Dx Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-15 2.5 Final 2023-09-15 Equity shares 2022-09-14 2.5 Final 2022-09-16 Equity shares 2021-09-14 1.0 Final 2021-09-16 Equity shares 2021-09-14 8.0 Special 2021-09-16 Equity shares 2020-03-19 0.7 Interim 2020-03-20 Equity shares 2019-09-17 0.5 Final 2019-09-19 Equity shares 2018-09-17 0.5 Final 2018-09-19 Equity shares 2017-09-15 0.3 Final 2017-09-19 Equity shares 2011-09-19 1.0 Final 2011-09-21 Equity shares 2007-09-18 1.0 Final 2007-09-20 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About 3B BlackBio Dx Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by 3B BlackBio Dx Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of 3B Blackbio DX Ltd?

Answer Field

The share price of 3B Blackbio DX Ltd for NSE is ₹ 0.00 and for BSE is ₹ 1480.00.

What is the Market Cap of 3B Blackbio DX Ltd?

Answer Field

The market cap of 3B Blackbio DX Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 12,57.20 Cr. as of now.

What is the 52 Week High and Low of 3B Blackbio DX Ltd?

Answer Field

The 52 Week High and Low of 3B Blackbio DX Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1550.00 and ₹ 660.00.

How to Buy 3B Blackbio DX Ltd share?

Answer Field

You can trade in 3B Blackbio DX Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for 3B Blackbio DX Ltd?

Answer Field

The 1 year returns on the stock has been 87.69%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text
loader